For obesity risk, in univariate model, model 1 and model 2, every 1-unit increase in serum RCAN2 concentrations was associated with an increased risk of 17.5%, 17.6% and 224.4%, respectively (Table 2). Here, RCAN2 is linked to obesity due to melanocortin 4 receptor deficiency.